Ethical Challenges in Online Drug Sales and Consumer Protection Policies

DOI: https://doi.org/10.63345/ijrmp.v13.i4.2

Yogesh Yadav

Independent Researcher

Chhattisgarh, India

Abstract

The rapid expansion of the digital marketplace has transformed the landscape of drug sales, opening new avenues for commerce that cross traditional regulatory and ethical boundaries. This manuscript explores the ethical challenges inherent in online drug sales and examines contemporary consumer protection policies designed to mitigate associated risks. The investigation addresses issues related to the sale of prescription and over-the-counter medications, the role of anonymity in online transactions, and the potential for abuse and harm. Additionally, the analysis considers the impact of globalization, technological innovation, and regulatory divergence across jurisdictions. Through a comprehensive literature review up to 2021, we synthesize existing research findings and highlight the multifaceted ethical dilemmas facing regulators, healthcare providers, and consumers. Our methodology combines qualitative content analysis with policy review to identify key trends and gaps in the current regulatory frameworks. The results indicate that while digital platforms offer increased access and convenience, they simultaneously challenge traditional ethical norms and pose significant risks regarding safety, quality control, and the equitable enforcement of consumer protection policies. The study concludes with recommendations for enhanced international collaboration, stricter verification processes, and the development of more adaptive legal frameworks that balance innovation with ethical responsibility.

Keywords

Online drug sales; ethical challenges; consumer protection; digital commerce; regulatory policies; healthcare ethics; policy review.

References

• https://www.google.com/url?sa=i&url=https%3A%2F%2Faseanconsumer.org%2Fcterms-consumer-protection&psig=AOvVaw1LBBbxKGKqtEGwG7yamqaP&ust=1741632960358000&source=images&cd=vfe&opi=89978449&ved=0CBQQjRxqFwoTCJiC9MHW_YsDFQAAAAAdAAAAABAE
• Baker, T., Johnson, M., & Lee, K. (2020). Technology and transparency in drug sales. Journal of Business Research, 117, 142–150.
• Chung, W., Patel, A., & Smith, D. (2018). Evaluating the safety of online pharmacies: A systematic review. Pharmacy Practice, 16(1), 95–100.
• Davis, E., & Kim, S. (2016). Ethical considerations in online pharmaceutical transactions. Ethics & Medicine, 32(1), 34–41.
• European Medicines Agency. (2018). Guidelines for online pharmaceutical commerce. EMA Reports.
• Garcia, M., Nguyen, P., & Thomas, R. (2016). The impact of digital platforms on pharmaceutical sales. Journal of Pharmaceutical Policy and Practice, 9, 17.
• Green, P., & Henderson, S. (2016). Consumer trust and online medication sales. Journal of Consumer Affairs, 50(4), 789–806.
• Harris, M., & Nguyen, T. (2021). Future directions in online drug regulation. Journal of Policy Analysis, 29(2), 210–225.
• Johnson, A. (2018). Digital anonymity and its implications in online drug sales. Cyberpsychology, Behavior, and Social Networking, 21(1), 55–60.
• Lee, K., & Wang, Y. (2017). Regulating e-health: Online drug sales and policy responses. Health Policy, 121(12), 1332–1339.
• Liu, X., & Kim, J. (2017). The regulatory challenge of digital pharmacies. Journal of Medical Internet Research, 19(3), 1–12.
• Martinez, L., Chen, H., & Davis, R. (2019). Health information online: Trust, safety, and regulation. Journal of Health Communication, 24(5), 506–516.
• O’Neill, D., Foster, S., & Patel, R. (2017). Global challenges in regulating online drug sales. Global Public Health, 12(7), 832–844.
• Patel, M., Roberts, L., & Singh, R. (2020). Consumer protection in the era of e-commerce. Journal of Business Ethics, 165(3), 449–462.
• Roberts, J. (2018). Counterfeit drugs and online pharmacies: A growing concern. British Journal of Clinical Pharmacology, 84(6), 1209–1215.
• Singh, R., & Patel, V. (2021). Blockchain applications in healthcare supply chains. Journal of Medical Systems, 45(3), 27–35.
• Smyth, L., O’Connor, D., & Riley, J. (2020). Blockchain technology in pharmaceutical supply chains. International Journal of Health Policy and Management, 9(4), 159–167.
• Thompson, R., Green, B., & Martin, C. (2019). Ethical challenges in digital health markets. Ethics in Information Technology, 21(2), 89–102.
• World Health Organization. (2019). Safety of online drug sales: Global perspectives and regulatory challenges. WHO Press.
• Williams, S., & Clark, H. (2018). The evolution of consumer protection laws in digital commerce. Legal Studies, 38(4), 567–582.
• Zhou, L., Martinez, F., & Gomez, P. (2019). Cross-border regulation of online pharmacies. Global Health Journal, 15(2), 94–102.